PyInvesting

Market research

002275.SHE Guilin Sanjin Pharmaceutical Co., Ltd

SHE CNY Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
8B
P/E ratio
17.18
Analyst target
15.92
Dividend yield
3.6%
Beta
0.17

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Guilin Sanjin Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 3.2% below its 200 day moving average.

From a valuation standpoint, the stock is 50.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.

Guilin Sanjin Pharmaceutical Co., Ltd's total revenue sank by 32.6% to $346M since the same quarter in the previous year.

Its net income has increased by 3.7% to $64M since the same quarter in the previous year.

Finally, its free cash flow grew by 506.8% to $21M since the same quarter in the previous year.

Based on the above factors, Guilin Sanjin Pharmaceutical Co., Ltd gets an overall score of 3/5.